Home › Cancro del polmone non a piccole cellule › Texas › Sugar Land
Studi clinici su Cancro del polmone non a piccole cellule a Sugar Land, TX
8 studi su Cancro del polmone non a piccole cellule cercano partecipanti presso sedi a Sugar Land e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
In reclutamentoFase 3
- Houston Methodist Sugar Land Hospital, Sugar Land
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
In reclutamentoFase 1
- The University of Texas, MD Anderson Cancer Center - Sugar Land, Sugar Land
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
In reclutamentoFase 3
- The University of Texas, MD Anderson Cancer Center - Sugar Land, Sugar Land
- Texas Oncology - Gulf Coast, Sugar Land
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
In reclutamentoFase 3
- Kelsey-Seybold Clinic - Fort Bend Campus, Sugar Land
- Texas Oncology - Gulf Coast, Sugar Land
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
In reclutamentoFase 3
- The University of Texas, MD Anderson Cancer Center - Sugar Land, Sugar Land
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
In reclutamentoFase 1/2
- Voyage Clinical, Sugar Land
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
In reclutamentoFase 3
- USO - Texas Oncology Gulf Coast, Sugar Land
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
In reclutamentoFase 2
- MD Anderson, Sugar Land
Studi su Cancro del polmone non a piccole cellule in altre città
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Altri studi a Sugar Land
- Obesità11 studi
- Sovrappeso10 studi
- Disturbi della sonnolenza eccessiva7 studi
- Cancro al seno7 studi
- Dermatite atopica (eczema)6 studi
- Malattia epatica steatosica6 studi
- Cancro ai polmoni6 studi
- Diabete di tipo 25 studi
- Disturbi del sonno5 studi
- Infezioni pneumococciche4 studi
- Narcolessia4 studi
- Cancro metastatico4 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.